Advertisement

International Journal of Clinical Pharmacy

, Volume 37, Issue 4, pp 583–591 | Cite as

Diagnostic evaluation and risk factors for drug allergies in children: from clinical history to skin and challenge tests

  • Tugba ArikogluEmail author
  • Gulen Aslan
  • Sehra Birgul Batmaz
  • Gulcin Eskandari
  • Ilter Helvaci
  • Semanur Kuyucu
Research Article

Abstract

Background Parent or self-reported drug allergy claims frequently overestimate the real incidence of hypersensitivity reactions. A detailed and algorithmic diagnostic evaluation of drug reactions may allow a proper diagnosis. Objective The aim of this study was to determine the confirmation rates and risk factors for confirmed allergic drug reactions in children. Setting Mersin University Hospital in Turkey. Method The study consisted of children between ages of 8 months and 18 years with the history of suspected drug allergy as reported by the clinician or the patients. Parents were interviewed by a clinician to complete questionnaires that included questions about demographic data and characteristics of index drug reaction. Immediate reactions (IRs) were assessed with immediate-reading skin prick (SPT) and intradermal tests (IDT). Nonimmediate reactions (NIRs) were assessed with SPT, both early and delayed reading of IDT and patch tests. In case of negative skin tests, drug provocation tests were performed. The possible risk factors for confirmed drug allergy in univariate analysis (p < 0.1) were entered into the multivariate logistic regression analysis to determine independent predictors. Main outcome measure (1) Confirmation rates of drug allergy (2) Risk factors related to confirmed drug allergy in children. Results We evaluated a total of 180 suspected drug allergy reactions in 97 children, mainly to antibiotics, non-steroidal anti-inflammatory drugs (NSAIDs) and anticonvulsants. Among all suspected allergic drug reactions, 97 (53.9 %) were immediate type and 83 (46.1 %) were non-immediate type. The average time interval between the reaction and allergologic work-up was 5 months. Drug allergy confirmation rates were 30.1 % for beta-lactams, 27.2 % for non-betalactams, 21.1 % for NSAIDs and 30 % for anticonvulsants. Eight of 54 confirmed NIRs showed positivity on immediate skin tests. Regulatory T cells, TGF-β and IL-10 levels were not different between groups with and without confirmed drug allergy. A strong family and personal history of drug allergy were found to be significantly related to the confirmed allergic drug reactions. Conclusion Parent or self-reported drug allergy should be evaluated with a standardized diagnostic work-up before strict prohibitions are made. In addition, family and personal histories of drug allergy were significant risk factors related to allergic drug reactions in children.

Keywords

Allergies Challenge tests Drug hypersensitivity IL-10 Regulatory T cells Skin tests TGF-beta 

Notes

Acknowledgments

We thank Mr Mustafa Goçeri and Mrs. Aysel Sari for their help in the diagnostic working of this study.

Funding

No special funding was received for this study.

Conflicts of interest

The authors of this manuscript do not have any conflicts of interest relating to this publication.

References

  1. 1.
    Lange L, Koningsbruggen SV, Rietschel E. Questionnaire-based survey of lifetime-prevalence and character of allergic drug reactions in German children. Pediatr Allergy Immunol. 2008;19(7):634–8.PubMedGoogle Scholar
  2. 2.
    Gomes E, Cardoso MF, Praca F, Gomes L, Marino E, Demoly P. Self-reported drug allergy in a general adult Portuguese population. Clin Exp Allergy. 2004;34(10):1597–601.PubMedCrossRefGoogle Scholar
  3. 3.
    Orhan F, Karakas T, Cakir M, Akkol N, Bahat E, Sonmez FM, et al. Parental-reported drug allergy in 6- to 9-yr-old urban schoolchildren. Pediatr Allergy Immunol. 2008;19(1):82–5.PubMedGoogle Scholar
  4. 4.
    Palma-Carlos AG, Medina G, Palma-Carlos ML. Prevalence of drug allergy in an out-patient population. Eur Ann Allergy Clin Immunol. 2006;38(5):142–5.PubMedGoogle Scholar
  5. 5.
    Miller GC, Britth HC, Valenti L. Adverse drug events in general practice patients in Australia. Med J Aust. 2006;184(7):321–4.PubMedGoogle Scholar
  6. 6.
    Sanchez-Borges M, Capriles-Hulett A. Atopy is a risk factor for non-steroidal anti-inflammatory drug sensitivity. Ann Allergy Asthma Immunol. 2000;84(1):101–6.PubMedCrossRefGoogle Scholar
  7. 7.
    Pastorello EA, Zara C, Riario-Sforza GG, Pravettoni V, Incorvaia C. Atopy and intolerance of antimicrobial drugs increase the risk of reactions to acetaminophen and nimesulide in patients allergic to nonsteroidal anti-inflammatory drugs. Allergy. 1998;53(9):880–4.PubMedCrossRefGoogle Scholar
  8. 8.
    Kurt E, Demir AU, Cadirci O, Yildirim H. Pinar Eser T. Immediate-type drug hypersensitivity and associated factors in a general population. Allergol Immunopathol. 2011;39(1):27–31.CrossRefGoogle Scholar
  9. 9.
    Langley J, Halperin S. Allergy to antibiotics in children: perception versus reality. Can J Infect Dis. 2002;13(3):160–3.PubMedCentralPubMedGoogle Scholar
  10. 10.
    Atanaskovic Markovic M, Velickovic TC, Gavrovic-Jankulovic M, Vuckovic O, Nestorovic B. Immediate allergic reactions to cephalosporins and penicillins and their cross-reactivity in children. Pediatr Allergy Immunol. 2005;16(4):341–7.PubMedCrossRefGoogle Scholar
  11. 11.
    Gomes ER, Fonseca J, Araujo L, Demoly P. Drug allergy claims in children: from self-reporting to confirmed diagnosis. Clin Exp Allergy. 2008;38(1):191–8.Google Scholar
  12. 12.
    Solensky R, Khan DA, Bernstein IL, Bloomberg GR, Castells MC, Mendelson LM, et al. Drug allergy: an updated practice parameter. Ann Allergy Asthma Immunol. 2010;105(4):259–73.CrossRefGoogle Scholar
  13. 13.
    Romano A, Caubet JC. Antibiotic allergies in children and adults: from clinical symptoms to skin testing diagnosis. J Allergy Clin Immunol Pract. 2014;2(1):3–12.PubMedCrossRefGoogle Scholar
  14. 14.
    Bousquet PJ, Gaeta F, Bousquet-Rouanet L, Lefrant JY, Demoly P, Romano A. Provocation tests in diagnosing drug hypersensitivity. Curr Pharm Des. 2008;14(27):2792–802.PubMedCrossRefGoogle Scholar
  15. 15.
    Palomares O, Martin Fontecha M, Lauener R, Traidl Hoffmann C, Cavkavtar O, Akdis M, et al. Regulatory T cells and immune regulation of allergic diseases: role of IL-10 and TGF-β. Genes Immun. 2014;15(8):511–20.PubMedCrossRefGoogle Scholar
  16. 16.
    Demoly P, Kropf R, Bircher A, Pichler WJ. Drug hypersensitivity: questionnaire. EAACI Interest group on drug hypersensitivity. Allergy. 1999;54(9):999–1003.PubMedCrossRefGoogle Scholar
  17. 17.
    Brockow K, Romano A, Blanca M, Ring J, Pichler W, Demoly P. General considerations for skin test procedures in the diagnosis of drug hypersensitivity. Allergy. 2002;57(1):45–51.PubMedGoogle Scholar
  18. 18.
    Aberer W, Bircher A, Romano A, Blanca M, Campi P, Fernandez J, et al. Drug provocation testing in the diagnosis of drug hypersensitivity reactions: general considerations. Allergy. 2003;58(9):854–63.PubMedCrossRefGoogle Scholar
  19. 19.
    Blanca M, Romano A, Torres MJ, Fernandez J, Mayorga C, Rodriguez J, et al. Update on the evaluation of hypersensitivity reactions to betalactams. Allergy. 2009;64(2):183–93.PubMedCrossRefGoogle Scholar
  20. 20.
    Brockow K, Garvey LH, Aberer W, Atanaskovic Markovic M, Barbaud A, Bilo MB, et al. Skin test concentrations for systemically administered drugs-an ENDA/EAACI drug allergy interest group position paper. Allergy. 2013;68(6):702–12.PubMedCrossRefGoogle Scholar
  21. 21.
    Barbaud A. Skin testing and patch testing in non-IgE mediated drug allergy. Curr Allergy Asthma Rep. 2014;14(6):442. doi: 10.1007/s11882-014-0442-8.PubMedCrossRefGoogle Scholar
  22. 22.
    Seitz CS, Brocker EB, Trautmann A. Diagnosis of drug hypersensitivity in children and adolescents: discrepancy between physician-based assessment and results of testing. Pediatr Allergy Immunol. 2011;22(4):405–10.PubMedCrossRefGoogle Scholar
  23. 23.
    Zambonino MA, Corzo JL, Munoz C, Requena G, Ariza A, Mayorga C, et al. Diagnostic evaluation of hypersensitivity reactions to beta-lactam antibiotics in a large population of children. Pediatr Allergy Immunol. 2014;25(1):80–7.PubMedCrossRefGoogle Scholar
  24. 24.
    Ponvert C, Le Clainche L, de Blic J, Le Bourgeois M, Scheinmann P, Paupe J. Allergy to beta-lactam antibiotics in children. Pediatrics. 1999;104(4):e45.PubMedCrossRefGoogle Scholar
  25. 25.
    Ponvert C, Perrin Y, Bados-Albiero A, Le Bourgeois M, Karila C, Delacourt C, et al. Allergy to betalactam antibiotics in children: results of a 20-year study based on clinical history, skin and challenge tests. Pediatr Allergy Immunol. 2011;22(4):411–8.PubMedCrossRefGoogle Scholar
  26. 26.
    Pichichero ME, Pichichero DM. Diagnosis of penicillin, amoxicillin and cephalosporin allergy: reliability of examination assessed by skin testing and oral challenge. J Pediatr. 1998;132(1):137–43.PubMedCrossRefGoogle Scholar
  27. 27.
    Benahmed S, Scaramuzza C, Messaad D, Sahla H, Demoly P. The accuracy of the diagnosis of suspected macrolide antibiotic hypersensitivity: results of a single-blinded trial. Allergy. 2004;59(10):1130–3.PubMedCrossRefGoogle Scholar
  28. 28.
    Seitz CS, Brocker EB, Trautmann A. Suspicion of macrolide allergy after treatment of infectious diseases including Helicobacter pylori: results of allergological testing. Allergol Immunopathol. 2011;39(4):193–9.CrossRefGoogle Scholar
  29. 29.
    Zambonino MA, Torres MJ, Munoz C, Requena G, Mayorga C, Posadas T, et al. Drug provocation tests in the diagnosis of hypersensitivity reactions to non-steroidal anti-inflammatory drugs in children. Pediatr Allergy Immunol. 2013;24(2):151–9.PubMedCrossRefGoogle Scholar
  30. 30.
    Yilmaz O, Karagol HE, Bakirtas A, Topal E, Celik GE, Demirsoy MS, et al. Challenge-proven nonsteroidal anti-inflammatory drug hypersensitivity in children. Allergy. 2013;68(12):1555–61.PubMedCrossRefGoogle Scholar
  31. 31.
    Blanca M, Torres MJ, Garcia JJ, Romano A, Mayorga C, de Ramon E, et al. Natural evolution of skin test sensitivity in patients allergic to beta-lactam antibiotics. J Allergy Clin Immunol. 1999;103:918–24.PubMedCrossRefGoogle Scholar
  32. 32.
    Hjortlund J, Mortz CG, Skov PS, Bindslev-Jensen C. Diagnosis of penicillin allergy revisited: the value of case history, skin testing, specific IgE and prolonged challenge. Allergy. 2013;68(8):1057–64.PubMedCrossRefGoogle Scholar
  33. 33.
    Bircher AJ, Scherer Hofmeier K. Drug hypersensitivity reactions: inconsistency in the use of the classification of immediate and nonimmediate reactions. J Allergy Clin Immunol. 2012;129(1):263–4.PubMedCrossRefGoogle Scholar
  34. 34.
    Stember RH. Prevalence of skin test reactivity in patients with convincing, vague and unacceptable histories of penicillin allergy. Allergy Asthma Proc. 2005;26(1):59–64.PubMedGoogle Scholar
  35. 35.
    Barbaud A, Reichert-Penetrat S, Trechot P, Jacquin-Petit MA, Ehlinger A, Noirez V, et al. The use of skin testing in the investigation of cutaneous adverse drug reactions. Br J Dermatol. 1998;139(1):49–58.PubMedCrossRefGoogle Scholar
  36. 36.
    Takahashi R, Kano Y, Yamazaki Y, Kimishima M, Mizukawa Y, Shiohara T. Defective Regulatory T cells in patients with severe drug eruptions: timing of the dysfunction is associated with the pathological phenotype and outcome. J Immunol. 2009;182(12):8071–9.PubMedCrossRefGoogle Scholar
  37. 37.
    Qiao HL, Wen Q, Gao N, Tian X, Jia LJ. Association of IL-10 level and IL-10 promoter SNPs with specific antibodies in penicillin-allergic patients. Eur J Clin Pharmacol. 2007;63(3):263–9.PubMedCrossRefGoogle Scholar
  38. 38.
    Lieber NS, Ribeiro E. Adverse drug reactions leading children to the emergency department. Rev Bras Epidemiol. 2012;15(2):265–74.PubMedCrossRefGoogle Scholar
  39. 39.
    Rashed AN, Wong IC, Cranswick N, Tomlin S, Rascher W, Neubert A. Risk factors associated with adverse drug reactions in hospitalised children: international multicentre study. Eur J Clin Pharmacol. 2012;68(5):801–10.PubMedCrossRefGoogle Scholar
  40. 40.
    Shiohara T, Kano Y. A complex interaction between drug allergy and viral infection. Clin Rev Allergy Immunol. 2007;33(1):124–33.PubMedCrossRefGoogle Scholar
  41. 41.
    Hassani A, Ponvert C, Karila C, Le Bourgeois M, De Blic J, Scheinmann P. Hypersensitivity to cyclooxygenase inhibitory drugs in children: a study of 164 cases. Eur J Dermatol. 2008;18(5):561–5.PubMedGoogle Scholar

Copyright information

© Koninklijke Nederlandse Maatschappij ter bevordering der Pharmacie 2015

Authors and Affiliations

  • Tugba Arikoglu
    • 1
    Email author
  • Gulen Aslan
    • 2
  • Sehra Birgul Batmaz
    • 1
  • Gulcin Eskandari
    • 3
  • Ilter Helvaci
    • 4
  • Semanur Kuyucu
    • 1
  1. 1.Department of Pediatric Allergy and Immunology, Faculty of MedicineMersin UniversityMersinTurkey
  2. 2.Department of Pediatrics, Faculty of MedicineMersin UniversityMersinTurkey
  3. 3.Department of Biochemistry, Faculty of MedicineMersin UniversityMersinTurkey
  4. 4.Department of Biostatistics, Faculty of MedicineMersin UniversityMersinTurkey

Personalised recommendations